Scribd
Upload
284 views

Session 1 Introduction To PICS GMP 009-14

This document provides an introduction and overview of the PIC/S Good Manufacturing Guide for Medicinal Products PE009-14. It discusses that PIC/S aims to harmonize GMP standards and inspection procedures worldwide. It outlines the key elements of GMP control according to PIC/S, including the pharmaceutical quality system, personnel, premises and equipment, documentation, production, quality control, outsourced activities, complaints and recalls, and self-inspection. The presentation also notes that PE009-14 is the latest version of the PIC/S GMP guide, revising some chapters and annexes.

Uploaded by

Elton Subijano
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
284 views

Session 1 Introduction To PICS GMP 009-14

This document provides an introduction and overview of the PIC/S Good Manufacturing Guide for Medicinal Products PE009-14. It discusses that PIC/S aims to harmonize GMP standards and inspection procedures worldwide. It outlines the key elements of GMP control according to PIC/S, including the pharmaceutical quality system, personnel, premises and equipment, documentation, production, quality control, outsourced activities, complaints and recalls, and self-inspection. The presentation also notes that PE009-14 is the latest version of the PIC/S GMP guide, revising some chapters and annexes.

Uploaded by

Elton Subijano
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 12

INTRODUCTION TO PIC/S GOOD

MANUFACTURING GUIDE FOR


MEDICINAL PRODUCTS PE009-14

MA. LYNN RACHELLE A. NATIVIDAD


Food-Drug Regulation Officer III
Drug GMP Inspectorate Manager
Regional Field Office-NCR
PRESENTATION OUTLINE

I. cGMP and AO 2012-008


II. Introduction to PIC/S and to the PIC/S GMP Guide
III. Overview of PIC/S GMP Guide for Medicinal Products Part I
IV. Intro to PE 009-14
GMP and cGMP
• The acronym GMP is used internationally to describe a set of principles
and procedures which, when followed by manufacturers of medical
goods, help ensure that the products manufactured will have the
required quality.
• GMP is the part of the quality management which ensures that
products are consistently produced and controlled to the quality
standards appropriate to their intended use and as required by the
marketing authorization, clinical trial authorization or product
specification. GMP is concerned with both production and quality
control , plus product and process design.
• A basic tenet of GMP is that quality cannot be tested into a batch of
product but must be built into each batch of product during all stages
of the manufacturing process.
• “c” means current
Objectives of GMP
➢ Provide consistent quality product Non-adherence to GMP!
➢ Maintain consistent, reproducible
processes
➢ Reduce the need of extensive testing
of each batch through quality
assurance
➢ Maintain the ability to reconstruct past
production through accurate records
➢ Develop the ability to predict future
process performance based on past
results
History of GMP in the Philippines
1974 The Philippines issued a set of GMP guidelines based on the
1967 WHO GMP Guide-
Administrative Order No. 220 s. 1974 (Drugs-Current Good
Manufacturing Practice in Manufacture, Processing, Packing
or Holding)

1999 Administrative Order No. 43 s. 1999 (Current Good


Manufacturing Practice for Drugs)

2004 The Agreement on the ASEAN Sectoral Integration Protocol


for Healthcare was signed

2007-2009 Establishment, Signing & Implementation of the Sectoral Recognition


Arrangement for GMP Inspection of Manufacturers of Medicinal Products
SECTORAL MUTUAL RECOGNITION ARRANGEMENT (Sectoral MRA)
PIC/S
The Pharmaceutical Inspection Co-operation Scheme (PIC/S) is a non-
binding, informal co-operative arrangement between Regulatory
Authorities in the field of Good Manufacturing Practice (GMP) of
medicinal products for human or veterinary use. It is open to any
Authority having a comparable GMP inspection system. PIC/S presently
comprises 54 Participating Authorities coming from all over the world
(Europe, Africa, America, Asia and Australasia).

PIC/S aims at harmonizing inspection procedures worldwide by


developing common standards in the field of GMP and by providing
training opportunities to Inspectors. It also aims at facilitating co-
operation and networking between competent authorities, regional and
international organizations, thus increasing mutual confidence. This is
reflected in PIC/S’ mission which is to lead the international
development, implementation and maintenance of harmonized GMP
standards and quality systems of inspectorates in the field of medicinal
products.
LEGAL BASIS FOR GMP STANDARD
A.O. 2012-0008 Adoption and Implementation of the
PIC/S Guides for Good Manufacturing Practice (GMP)
for Medicinal Products
PIC/S GMP Guide-General
• Consists of Introduction, Part I, Part II and Annexes
(20) www.fda.gov.ph www.picscheme.org
PIC/S GMP Part II and Annexes
Part II- provides guidance regarding GMP for the manufacturing of active
pharmaceutical ingredients (APIs) under an appropriate system for managing
quality.

Annexes- 20 Annexes
Annex 1- Manufacture of Sterile Medicinal Products
Annex 2- Manufacture of biological medicinal substance and products for
human use
Annex 3- Manufacture of Radiopharmaceuticals
Annex 6 – Manufacture of Medicinal Gases
Annex 7 – Manufacture of herbal medicinal products
Annex 15 – Qualification and Validation
PIC/S GMP Part I
• There are 9 key elements in Part I that need
to be controlled in order for GMP to be in
place:
1. Pharmaceutical Quality System
2. Personnel
3. Premises and Equipment
4. Documentation
5. Production
6. Quality control
7. Outsourced Activities
8. Complaints and product recall
9. Self-inspection
PE 009-14 version of the PIC/S GMP
PE009-14 issued on July 1, 2018

Part I- Revision of:


Chapters 3- Premises and Equipment
Chapter 5- Production
Chapter 8- Complaints and Product Recall

Annex-Revision of Annex 17 (Real Time Release Testing


and Parametric Release)
END

THANK YOU!

www.fda.gov.ph [email protected]

You might also like